Vitamin D status at breast cancer diagnosis: Correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency

Carcinogenesis

Volumn 33, Issue 7, 2012, Pages 1319-1326

  Hatse, Sigrid ^a   Lambrechts, Diether ^a,b   Verstuyf, Annemieke ^c   Smeets, Ann ^a   Brouwers, Barbara ^a,b   Vandorpe, Thijs ^b   Brouckaert, Olivier ^b   Peuteman, Gilian ^a,c   Laenen, Annouschka ^d   Verlinden, Lieve ^a   Kriebitzsch, Carsten ^a   Dieudonné, Anne Sophie ^b   Paridaens, Robert ^b   Neven, Patrick ^b   Christiaens, Marie Rose ^b   Bouillon, Roger ^a   Wildiers, Hans ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d Interuniversity Centre for Biostatistics and Statistical Bioinformatics   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIFEDIOL; CYP2R1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE FREE INTERVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; TUMOR VOLUME; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84865169159     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs187     Document Type: Article

References (50)

1. Zittermann,A. (2003) Vitamin D in preventive medicine: are we ignoring the evidence? Br. J. Nutr., 89, 552-572.
2. Blaney,G.P. et al. (2009) Vitamin D metabolites as clinical markers in autoimmune and chronic disease. Ann. N. Y. Acad. Sci., 1173, 384-390.
3. Verstuyf,A. et al. (2010) Vitamin D: a pleiotropic hormone. Kidney Int., 78, 140-145.
4. Garland,F.C. et al. (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev. Med., 19, 614-622.
5. Grant,W.B. et al. (2005) Comparisons of estimated economic burdens due to insufficient solar ultraviolet irradiance and vitamin D and excess solar UV irradiance for the United States. Photochem. Photobiol., 81, 1276-1286.
6. Bao,Y. et al. (2010) Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies. Br. J. Cancer, 102, 1422-1427.
7. Davis,C.D. (2008) Vitamin D and cancer: current dilemmas and future research needs. Am. J. Clin. Nutr., 88, 565S-569S.
8. Freedman,D.M. et al. (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J. Natl. Cancer Inst., 99, 1594-1602.
9. Gorham,E.D. et al. (2007) Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am. J. Prev. Med., 32, 210-216.
10. Yin,L. et al. (2010) Meta-analysis: serum vitamin D and breast cancer risk. Eur. J. Cancer, 46, 2196-2205.
11. Chen,P. et al. (2010) Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res. Treat., 121, 469-477.
12. Bolland,M.J. et al. (2011) Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am. J. Clin. Nutr., 94, 1144-1149.
13. Manson,J.E. et al. (2011) Vitamin D and prevention of cancer-ready for prime time? N. Engl. J. Med., 364, 1385-1387.
14. Wactawski-Wende,J. et al. (2006) Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med., 354, 684-696.
15. Palmieri,C. et al. (2006) Serum 25-hydroxyvitamin D levels in early and advanced breast cancer. J. Clin. Pathol., 59, 1334-1336.
16. Goodwin,P.J. et al. (2009) Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J. Clin. Oncol., 27, 3757-3763.
17. Zhou,W. et al. (2007) Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J. Clin. Oncol., 25, 479-485.
18. Ng,K. et al. (2008) Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J. Clin. Oncol., 26, 2984-2991.
19. Newton-Bishop,J.A. et al. (2009) Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J. Clin. Oncol., 27, 5439-5444.
20. Drake,M.T. et al. (2010) Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J. Clin. Oncol., 28, 4191-4198.
21. Freedman,D.M. et al. (2010) Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res., 70, 8587-8597.
22. Napoli,N. et al. (2010) High prevalence of low vitamin D and musculoskeletal complaints in women with breast cancer. Breast J., 16, 609-616.
23. Lester,J.E. et al. (2006) Current management of treatment-induced bone loss in women with breast cancer treated in the United Kingdom. Br. J. Cancer, 94, 30-35.
24. Hines,S.L. et al. (2010) Breast cancer survivors and vitamin D: a review. Nutrition, 26, 255-262.
25. Goodwin,P.J. (2009) Vitamin D in cancer patients: above all, do no harm. J. Clin. Oncol., 27, 2117-2119.
26. Bouillon,R. (2010) Genetic and environmental determinants of vitamin D status. Lancet, 376, 148-149.
27. Wang,T.J. et al. (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet, 376, 180-188.
28. Prosser,D.E. et al. (2004) Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem. Sci., 29, 664-673.
29. Janssens,W. et al. (2010) Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax, 65, 215-220.
30. Brouckaert,O. et al. (2009) Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors. Breast Cancer Res. Treat., 115, 349-358.
31. Norman,A.W. et al. (2010) Vitamin D nutritional policy needs a vision for the future. Exp. Biol. Med., 235, 1034-1045.
32. Institute of Medicine (IOM). (2011) Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press, Washington, DC.
33. Holick,M.F. et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab., 96, 1911-1930.
34. Rubin,D. (1976) Inference and missing data. Biometrika, 63, 581-592.
35. Rubin,D. (ed) (1987) Multiple Imputation for Non-Response in Surveys. Wiley, New York, NY.
36. Benjamini,Y. et al. (1995) Controlling the false discovery rate-a practical and powerful approach to multiple testing. J. Roy. Stat. Soc. B, 57, 289-300.
37. Parmar,M. et al. (eds) (1995) Survival Analysis: A Practical Approach. Wiley, Chichester, England.
38. Zmuda,J.M. et al. (2000) Molecular epidemiology of vitamin D receptor gene variants. Epidemiol. Rev., 22, 203-217.
39. Slattery,M.L. (2007) Vitamin D receptor gene (VDR) associations with cancer. Nutr. Rev., 65, S102-S104.
40. Yao,S. et al. (2011) Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study. PLoS One, 6, e17251.
41. Narvaez,C.J. et al. (2001) Functions of 1alpha,25-dihydroxyvitamin D(3) in mammary gland: from normal development to breast cancer. Steroids, 66, 301-308.
42. Welsh,J. (2007) Targets of vitamin D receptor signaling in the mammary gland. J. Bone Miner. Res., 22 (suppl. 2), V86-V90.
43. Zittermann,A. et al. (2012) Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am. J. Clin. Nutr., 95, 91-100.
44. Schottker,B. et al. (2012) Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res. Rev., in press.
45. Coleman,R.E. et al. (2011) Breast-cancer adjuvant therapy with zoledronic acid. N. Engl. J. Med., 365, 1396-1405.
46. Prieto-Alhambra,D. et al. (2011) Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study. Breast Cancer Res. Treat., 125, 869-878.
47. Nechuta,S. et al. (2011) Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study. Cancer Epidemiol. Biomarkers Prev., 20, 262-271.
48. Porojnicu,A.C. et al. (2007) Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway. Breast Cancer Res. Treat., 102, 323-328.
49. Robsahm,T.E. et al. (2004) Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control,15, 149-158.
50. Van Renterghem,D. (2007) Lung cancer survival: vitamin D could be just a marker of physical fitness. J. Clin. Oncol., 25, 5537-5538; author reply 5538-5539.